LEO32731

DRUG2 trials

Sponsors

LEO Pharma

Conditions

Psoriasis Vulgaris

Phase 1

LP0058-1005 - A Open-Label, Four-Way Crossover and Food-Effect Study of LEO 32731 in Healthy Subjects

CompletedNCT02126371

LEO PharmaPsoriasis Vulgaris

Start: 2014-05-31End: 2015-01-31Updated: 2016-06-14

LEO 32731 - A Phase I Study in Healthy Subjects

CompletedNCT02514694

LEO PharmaPsoriasis Vulgaris

Start: 2015-07-31End: 2015-12-31Updated: 2017-05-03